Neuren Pharmaceuticals | NEU - Selling And Administration Expenses

Stock Price
12.79
Daily Change
-0.06 -0.47%
Monthly
2.48%
Yearly
-3.03%
Q2 Forecast
12.56

Neuren Pharmaceuticals reported AUD3.74M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 585K 84K Sep/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Clinuvel Pharmaceuticals AUD 3.85M 5.27M Dec/2025
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Genetic Signatures AUD 908K 31K Dec/2025
Ionis Pharmaceuticals USD 151M 21M Mar/2026
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organon & Co USD 433M 34M Dec/2025
Paradigm Biopharmaceuticals AUD 2.83M 1.22M Dec/2025
PYC Therapeutics AUD 328.4K 1.8M Dec/2025
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Tectonic Therapeutic USD 3.44M 1.52M Dec/2025
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025
Viatris USD 928.8M 101.9M Mar/2026
Xeris Pharmaceuticals USD 42.64M 3.82M Dec/2025